Ferrous Fumarate

Description

Ferrous Fumarate is used for the treatment and prevention of iron deficiency anemia when the amount of iron taken in from the diet is not sufficient. It is also be used to treat anemia associated with chronic kidney failure. This medicine is used only to treat hemoglobin abnormalities due to iron deficiency.

Side effects

Major & minor side effects for Ferrous Fumarate

  • Dizziness
  • Headache
  • Constipation
  • Nausea or Vomiting
  • Diarrhea
  • Dark stools
  • Darker Urine
  • Heartburn
  • Teeth discolouration

Uses of Ferrous Fumarate

What is it prescribed for?

  • Iron Deficiency Anemia
Read More
Concerns

Commonly asked questions

  • Onset of action
    The amount of time required for this medicine to increase the hemoglobin levels in the body is 2 to 4 weeks.
  • Duration of effect
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Safe with alcohol?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is it habit forming?
    No habit-forming tendencies were reported.
  • Usage in pregnancy?
    This medicine is not recommended for use in pregnant women unless necessary. However, your doctor may prescribe this medicine if the benefits significantly outweigh the risks. The risks and benefits should be discussed with the doctor before taking this medicine.
  • Usage while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless necessary. However, your doctor may prescribe this medicine if the benefits significantly outweigh the risks. The risks and benefits should be discussed with the doctor before taking this medicine.

Allergy

This medicine is not recommended for use in patients with a known allergy to ferrous fumarate, other iron supplements or any other inactive ingredients present along with it.

Hemosiderosis

This medicine is not recommended for use in patients with hemosiderosis (a condition of excess iron in the body) due to the risk of adverse effects.

Hemochromatosis

This medicine is not recommended for use in patients with hemochromatosis (a condition of excess iron in the body) due to the risk of adverse effects.

Hemolytic anemia

This medicine is not recommended for use in patients with hemolytic anemia (a condition of an abnormal breakdown of red blood cells) unless an iron-deficient state is also present.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless necessary. However, your doctor may prescribe this medicine if the benefits significantly outweigh the risks. The risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless necessary. However, your doctor may prescribe this medicine if the benefits significantly outweigh the risks. The risks and benefits should be discussed with the doctor before taking this medicine.
General warnings

Achlorhydria

This medicine may have to be used in higher dosages in patients with achlorhydria, a state of decreased gastric secretions of the stomach to achieve the desired effect. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Gastrointestinal disorders

This medicine should be used with caution in patients with gastrointestinal irritation or conditions such as peptic ulcer disease, enteritis, ulcerative colitis, etc. due to the risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Use in children

This medicine should be used with extreme caution in children aged less than 6 years due to the risk of severe iron toxicity. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition. Accidental overdose of this medicine may lead to fatal iron poisoning in children below 6 years of age. All iron preparations must be kept away from the reach of children. Seek emergency medical treatment or contact the doctor in case of a suspected overdose.

Use in elderly population

This medicine should be used with extreme caution in elderly patients due to the risk of adverse effects. Close monitoring of the clinical condition, appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Missed Dose

Take the missed dose as soon as you remember. If it is almost time for the next scheduled dose, then the missed dose can be skipped. Do not use extra medicine to make up for the missed dose.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Dolutegravir

Levofloxacin

Dimercaprol

Nalidixic acid

Disease interactions

Disease

Information not available.
Food interactions
Information not available.
Lab interactions
Information not available.
Take Ferrous Fumarate as instructed by your doctor. Do not take in larger or smaller quantities or for longer than recommended. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Does not cause sleepiness

How it works
This medicine helps the body to make more red blood cells.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Iron products

Schedule

OTC

Ferrous fumarate - DrugBank [Internet]. Drugbank.ca. 2018 [cited 16 November 2018]. Available from:

https://www.drugbank.ca/drugs/DB14491

Ferrous fumarate [Internet]. Pubchem.ncbi.nlm.nih.gov. 2019 [cited 9 April 2019]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/Ferrous_fumarate

[Internet]. Medicines.org.uk. 2018 [cited 16 November 2018]. Available from:

https://www.medicines.org.uk/emc/files/pil.2821.pdf

How will this medicine affect me?

Consult top doctors online and get an answer now
Chat now

Looking for a doctor?

Book an appointment with the top doctors near you
Book now
Something doesn’t feel right?
Report an error

Information on this page was last updated on 16 May 2019

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.